Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.
about
Copper containing intra-uterine devices versus depot progestogens for contraceptionLong-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive deviceReview of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine systemCriterion-based screening for sexually transmitted infection: sensitivity, specificity, and predictive values of commonly used questionsUnderstanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United StatesComparing the effect of mefenamic Acid and vitex agnus on intrauterine device induced bleedingStrategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatmentSame-day intrauterine device placement is rarely complicated by pelvic infection.Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine deviceIntrauterine devices & infection: review of the literature.The effects of a single cervical inoculation of Chlamydia trachomatis on the female reproductive tract of the baboon (Papio anubis)Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trialPopulation attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data.Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.Living with uncertainty: acting in the best interests of womenFeasibility of LNG-IUS in a baboon model.Imaging of intrauterine contraceptive devices.Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health OutcomesContraception for cancer survivors.Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infectionThe copper intrauterine device for emergency contraception: an opportunity to provide the optimal emergency contraception method and transition to highly effective contraception.Long-acting reversible contraception: a review in special populations.Consequences of emergency contraceptives: the adverse effects.Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.Contraception for adolescents with chronic rheumatic diseases.Trends and determinants of IUD use in the USA, 2002-2012.Simultaneous prevention of unintended pregnancy and STIs: a challenging compromise.
P2860
Q24234768-625BC5DD-BF00-40CE-B992-D8E7F68D07F5Q24616425-35D850C6-FE9E-4E49-8ABE-D60D58058CECQ24646966-DDEB6855-3C06-4377-AC2B-54A2A6F4012CQ33827138-EE620BFC-45EE-4985-BFA9-F3EE4C46CFAFQ33875057-BB33BFC3-2D18-4EAD-B45A-2FD914CFAEA9Q34050381-991038A4-9306-4D7C-91DC-8B6F2348A11FQ34126221-6C3B782A-FCD2-490E-AED0-E70CEFDC3B0FQ34387781-556BF420-5302-420E-B75F-F11906D64E52Q34764933-872C1E65-5323-4459-ACD8-178D79FE3F8AQ34928698-19847BCF-789C-4E64-A08A-796D909F6CAAQ35135264-2C5F46DF-F907-4878-A762-C09E29A72768Q35557129-781A4D4C-FA95-4D62-B0C1-05D367720E26Q35755652-438AC55B-5E44-4027-809F-071B37B38CA0Q35993319-7F380737-1F52-43A5-A571-836EF574C400Q36075286-08673662-2CFD-468A-BE3D-6C2B7F01CE5CQ36410468-F59965B7-A4D8-46F0-8DE7-78B57F52E43DQ36589355-14F09583-3E8A-490A-BCDB-0688E5BDE698Q36954030-689D99E6-CABB-4390-9D53-FE056702A4BEQ37252765-67222F60-1650-4B17-BA49-E07BE13EDD34Q37390053-CD118CB0-8467-4EE6-B027-5F7F1531E120Q37445216-1031DB76-556D-4B72-9591-0D9286DA6BAAQ38124888-96B1320C-2597-47BB-9CD7-602283004F36Q38153019-00572DF8-8161-40F4-B3E7-2C9E30A53693Q38219426-8B040380-9EA6-4282-B269-564F6CF1574FQ38358383-7B812B53-A4B3-4D62-A05F-E19D4F4AED93Q38922218-51E23034-1E0B-41BD-BBB0-55FCF3C613B5Q39717421-A5D22E0C-E082-4E5D-A1D8-9A6987FF20BDQ43408739-D373A53B-442E-4C2A-806D-0986C4C558DA
P2860
Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Does insertion and use of an i ...... nfection? A systematic review.
@ast
Does insertion and use of an i ...... nfection? A systematic review.
@en
Does insertion and use of an i ...... nfection? A systematic review.
@nl
type
label
Does insertion and use of an i ...... nfection? A systematic review.
@ast
Does insertion and use of an i ...... nfection? A systematic review.
@en
Does insertion and use of an i ...... nfection? A systematic review.
@nl
prefLabel
Does insertion and use of an i ...... nfection? A systematic review.
@ast
Does insertion and use of an i ...... nfection? A systematic review.
@en
Does insertion and use of an i ...... nfection? A systematic review.
@nl
P2093
P921
P1433
P1476
Does insertion and use of an i ...... nfection? A systematic review.
@en
P2093
Anshu P Mohllajee
Herbert B Peterson
Kathryn M Curtis
P304
P356
10.1016/J.CONTRACEPTION.2005.08.007
P577
2005-10-19T00:00:00Z